Free shipping on all orders over $ 500

Cagrilintide acetate

Cat. No. M28370
Cagrilintide acetate Structure
Size Price Availability Quantity
5mg USD 450  USD450 In stock
10mg USD 710  USD710 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Cagrilintide acetate is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity.

Chemical Information
Molecular Weight 4469.06
Formula C196H316N54O61S2
CAS Number 1415456-99-3 (free base)
Storage -20°C, protect from light, dry, sealed
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] David C W Lau, et al. Lancet. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

[2] Donna H Ryan. Handb Exp Pharmacol. Drugs for Treating Obesity

[3] Thomas Kruse, et al. J Med Chem. Development of Cagrilintide, a Long-Acting Amylin Analogue

[4] Lone B Enebo, et al. Lancet. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial

[5] Sara Becerril, et al. Lancet. Cagrilintide plus semaglutide for obesity management

Related CGRP Receptor Products
Adrenomedullin (16-31), human

Adrenomedullin (16-31), human is amino acid residues 16-31 fragment of human adrenomedullin (hADM).

α-CGRP(human)

α-CGRP(human) is a regulatory neuropeptide of 37 amino acids.

Adrenomedullin (AM) (22-52), human

Adrenomedullin (AM) (22-52), human is an adrenomedullin receptor antagonist, and also antagonizes the calcitonin generelated peptide (CGRP) receptor in the hindlimb vascular bed of the cat.

Calcitonin Gene Related Peptide (CGRP) II, rat

Calcitonin Gene Related Peptide (CGRP) II, rat, a CGRP receptor activator, is a potent and long-lasting vasodilator.

Adrenomedullin (11-50), rat

Adrenomedullin (11-50), rat is the C-terminal fragment (11-50) of rat adrenomedullin.

  Catalog
Abmole Inhibitor Catalog




Keywords: Cagrilintide acetate supplier, CGRP Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.